Generex social media post today: BioSpace has
Post# of 36536
(Total Views: 321)
Posted On: 01/27/2021 12:15:44 PM
Generex social media post today:
BioSpace has listed the FDA approval of Trodelvy for TNBC as one of the biggest new drug approvals in 2020. NuGenerex Immuno-Oncology hopes to soon join the fight against TNBC with its Ii-key HER2/neu (AE37) vaccine not just to target the cancer with an antibody and payload, but to generate memory immunity against it.
#tnbc #coronavirusvaccine #sarscov2 #immunology #immunotherapy #tcells #biotechnology #clinicaltrial #Iikeypeptide
BioSpace has listed the FDA approval of Trodelvy for TNBC as one of the biggest new drug approvals in 2020. NuGenerex Immuno-Oncology hopes to soon join the fight against TNBC with its Ii-key HER2/neu (AE37) vaccine not just to target the cancer with an antibody and payload, but to generate memory immunity against it.
#tnbc #coronavirusvaccine #sarscov2 #immunology #immunotherapy #tcells #biotechnology #clinicaltrial #Iikeypeptide
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼